Neurohumoral and Endothelial Responses to Heated Water-Based Exercise in Resistant Hypertensive Patients
Carregando...
Citações na Scopus
26
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
JAPANESE CIRCULATION SOC
Autores
Citação
CIRCULATION JOURNAL, v.81, n.3, p.339-345, 2017
Resumo
Background: The neurohumoral and endothelial responses to the blood pressure (BP) lowering effects of heated water- based exercise (HEx) in resistant hypertension (HT) patients remain undefined. Methods and Results: We investigated these in 44 true resistant HT patients (age 53.3 +/- 0.9 years, mean +/- SEM). They were randomized and allocated to 2 groups, 28 to a HEx training protocol, which consisted of callisthenic exercises and walking in a heated pool for 1 h, three times weekly for 12 weeks and 16 patients to a control group maintaining their habitual activities. Measurements made before and after 12 weeks of HEx included clinic and 24-h BP, plasma levels of nitric oxide, endothelin- 1, aldosterone, renin, norepinephrine and epinephrine, as well as peak V. O2, and endothelial function (reactive hyperemia). After 12 weeks of HEx patients showed a significant decrease in clinic and 24- h systolic and diastolic BPs. Concomitantly, nitric oxide increased significantly (from 25 +/- 8 to 75 +/- 24 mu mol/ L, P < 0.01), while endothelin-1 (from 41 +/- 5 to 26 +/- 3 pg/ mL), renin (from 35 +/- 4 to 3.4 +/- 1 ng/mL/h), and norepinephrine (from 720 +/- 54 to 306 +/- 35 pg/ mL) decreased significantly (P < 0.01). Plasma aldosterone also tended to decrease, although not significantly (from 101 +/- 9 to 76 +/- 4 pg/ mL, P=NS). Peak VO2 increased significantly after HEx (P < 0.01), while endothelial function was unchanged. No significant change was detected in the control group. Conclusions: The BP-lowering effects of HEx in resistant HT patients were accompanied by a significant reduction in the marked neurohumoral activation characterizing this clinical condition.
Palavras-chave
Endothelial dysfunction, Heated water-based exercise, Neurohumoral activation, Resistant hypertension
Referências
- Beck DT, 2013, EXP BIOL MED, V238, P433, DOI 10.1177/1535370213477600
- Calhoun DA, 2008, CIRCULATION, V117, pE510, DOI 10.1161/CIRCULATIONAHA.108.189141
- Carvalho VO, 2009, CIRC J, V73, P1871
- Cuspidi C, 2010, J AM SOC HYPERTENS, V4, P319, DOI 10.1016/j.jash.2010.10.003
- Dimeo F, 2012, HYPERTENSION, V60, P653, DOI 10.1161/HYPERTENSIONAHA.112.197780
- Dobrowolski P, 2015, HYPERTENS RES, V38, P545, DOI 10.1038/hr.2015.39
- Ezzahti M, 2014, J HYPERTENS, V32, P135, DOI 10.1097/HJH.0b013e3283658ef7
- Figueiredo VN, 2012, BLOOD PRESSURE, V21, P31, DOI 10.3109/08037051.2011.617045
- Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245
- GRASSI G, 1988, HYPERTENSION, V12, P227
- GRASSI G, 1992, CHEST, V101, pS312, DOI 10.1378/chest.101.5_Supplement.312S
- Grassi G, 1999, J HYPERTENS, V17, P719, DOI 10.1097/00004872-199917060-00001
- Grassi G, 2015, HYPERTENSION, V65, P1209, DOI 10.1161/HYPERTENSIONAHA.114.04823
- Grassi G, 2015, CIRC RES, V116, P976, DOI 10.1161/CIRCRESAHA.116.303604
- Grassi G, 2014, INT J CARDIOL, V177, P1020, DOI 10.1016/j.ijcard.2014.09.138
- Guimaraes GV, 2014, INT J CARDIOL, V172, P434, DOI 10.1016/j.ijcard.2014.01.100
- Guimaraes GV, 2012, CARDIOVASC THER, V30, P351, DOI 10.1111/j.1755-5922.2011.00285.x
- HJEMDAHL P, 1979, LIFE SCI, V25, P131, DOI 10.1016/0024-3205(79)90384-9
- Jain A, 2012, AM J PATHOL, V180, P2309, DOI 10.1016/j.ajpath.2012.03.005
- Kinugawa T, 1997, CARDIOLOGY, V88, P238, DOI 10.1159/000177336
- Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc
- Meredith-Jones K, 2011, COMPLEMENT THER MED, V19, P93, DOI 10.1016/j.ctim.2011.02.002
- Moerland M, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/904141
- Nohria A, 2006, J APPL PHYSIOL, V101, P545, DOI 10.1152/japplphysiol.01285.2005
- O'Brien E, 1991, J HYPERTENS, V9, P9
- OJIMA M, 1978, TOHOKU J EXP MED, V124, P367
- Oparil S, 2015, CIRC RES, V116, P1074, DOI 10.1161/CIRCRESAHA.116.303603
- Pabuccu T, 2012, CLIN EXP HYPERTENS, V34, P57, DOI 10.3109/10641963.2011.618203
- Pechter U, 2003, INT J REHABIL RES, V26, P153, DOI 10.1097/01.mrr.0000070755.63544.5a
- Pickering Thomas G, 2007, J Clin Hypertens (Greenwich), V9, P390, DOI 10.1111/j.1524-6175.2007.06300.x
- Romitelli F, 2007, J CHROMATOGR B, V851, P257, DOI 10.1016/j.jchromb.2007.02.003
- Santos LP, 2016, J HYPERTENS, V34, P1317, DOI 10.1097/HJH.0000000000000961
- Schmid JP, 2007, HEART, V93, P722, DOI 10.1136/hrt.2006.094870
- SEALEY JE, 1977, CARDIOVASC MED, V2, P1079
- Shimosawa T, 2013, HYPERTENS RES, V36, P657, DOI 10.1038/hr.2013.69
- te Riet L, 2015, CIRC RES, V116, P960, DOI 10.1161/CIRCRESAHA.116.303587
- Townsend RR, 2014, SEMIN NEPHROL, V34, P506, DOI 10.1016/j.semnephrol.2014.08.004
- White DW, 2014, J PHYSIOL-LONDON, V592, P2491, DOI 10.1113/jphysiol.2014.271858